MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M&W GOVERNMENT AFFAIRS, LLC) for EMERGENT BIOSOLUTIONS INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA Regulatory Issues; Issues Related to Priority Review Voucher Programs; Opioid and Heroin addiction legislation, naloxone access, coprescribing/opioid prescribing guidelines
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MILNE | — |
| JEFFREY S WIENER | — |
Defense DEF
FY2020 National Defense Authorization Act provisions related to biological and chemical defense; FY202 Defense Appropriations for Medical Countermeasures
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MILNE | — |
| JEFFREY S WIENER | LA, US Senate |
Budget/Appropriations BUD
FY 2020 Appropriations Provisions Related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government FY 2020 Defense Appropriations for Medical Countermeasures
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MILNE | — |
| JEFFREY S WIENER | LA, US Senate |
Homeland Security HOM
FY 2020 Appropriations Provisions Related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Re-Authorization of the Pandemic and All-Hazards Preparedness Act;
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MILNE | — |
| JEFFREY S WIENER | LA, US Senate |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.